Tongfang Kontafarma Holdings Overview
- Founded
-
1993
- Status
-
Public
- Employees
-
1,365
- Stock Symbol
-
01312
- Investments
-
2
Tongfang Kontafarma Holdings General Information
Description
Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises.
Contact Information
Website
www.kontafarma.com.hk
Formerly Known As
Allied Cement Holdings
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Stock Exchange
HKG
Primary Office
- 9th Floor, Allied Kajima Building
- 138 Gloucester Road, Wanchai
- Hong Kong
- Hong Kong
+852 2111 0000
Tongfang Kontafarma Holdings Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $39.9M | 5.59B | 2.34M |
Tongfang Kontafarma Holdings Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 122,056 | 129,848 | 219,489 | 275,994 |
| Revenue | 131,603 | 123,646 | 130,094 | 117,558 |
| EBITDA | 25,190 | 22,595 | 20,065 | 30,176 |
| Net Income | 3,751 | (1,936) | (34,442) | 4,607 |
| Total Assets | 313,407 | 328,130 | 327,937 | 513,593 |
| Total Debt | 74,683 | 93,479 | 100,951 | 115,301 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tongfang Kontafarma Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tongfang Kontafarma Holdings Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Chaowen Jiang | Chief Executive Officer, Executive Director & Vice President | ||
| Hongjie Chai | Executive Director |
Tongfang Kontafarma Holdings Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Tongfang Kontafarma Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tongfang Kontafarma Holdings Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 03-May-2018 | 000000000 | 000.00 | Pharmaceuticals | |
| Tongfang Pharmaceutical Group | 28-Jan-2016 | Secondary Transaction - Private | 000.00 | Pharmaceuticals |
Tongfang Kontafarma Holdings Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 000000000 | Pharmaceuticals | Beijing, China | 0000 |
Tongfang Kontafarma Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Construction Materials
Industry
Rank
Percentile
Construction Materials
Subindustry
Rank
Percentile
